Zugriffe | |
---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 391 |
Februar 2025 | März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | August 2025 | |
---|---|---|---|---|---|---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 0 | 21 | 9 | 3 | 11 | 19 | 8 |
Zugriffe | |
---|---|
3_Chapter3_Materials_Methods.pdf | 289 |
6_Chapter6_References.pdf | 286 |
1_Chapter1_Introduction_aims_objectives.pdf | 218 |
0_Title_Index.pdf | 179 |
7_Chapter7_Appendices_Aknowledgements.pdf | 177 |
2_Chapter2_Literature_review.pdf | 147 |
4_Chapter4_Results_Discussions.pdf | 138 |
5_Chapter5_Summary_Zusammenfassung.pdf | 97 |